|
|
|
|
|
|
Sponsored by: |
Logan College of Chiropractic |
Information provided by: | Logan College of Chiropractic |
ClinicalTrials.gov Identifier: | NCT00459680 |
To determine the effect of acupuncture and laser acupuncture point treatment on hypertensive subjects.
Condition | Intervention | Phase |
Hypertension |
Device: Laser acupoint treatment Procedure: Acupuncture |
Phase I |
MedlinePlus related topics: | Acupuncture High Blood Pressure |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Acupuncture and Laser Acupoint Treatment on Hypertension |
Estimated Enrollment: | 30 |
Study Start Date: | February 2008 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
Acupuncture: Experimental |
Procedure: Acupuncture
Needle acupuncture on ST36 and LI11.
|
Laser Acupoint: Experimental |
Device: Laser acupoint treatment
Laser
|
The specific aims of the study are to test the effectiveness of acupuncture and laser acupoint on hypertension. The hypothesis is: the stimulation of a pattern of acupoints with acupuncture and laser will result in significant reductions in blood pressure. The points that are going to be used for the study are: Zusanli (St36), Tianshu (St25), Quchi (LI11).
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Missouri | |||||
Logan College of Chiropractic | Recruiting | ||||
Chesterfield, Missouri, United States, 63017 | |||||
Contact: John Zhang, MD, PhD 636-230-1920 john.zhang@logan.edu |
Logan College of Chiropractic |
Principal Investigator: | John Zhang, MD. PhD | Logan College of Chiropractic |
Responsible Party: | Logan College of Chiropractic ( John Zhang ) |
Study ID Numbers: | LCC-05-06 |
First Received: | April 10, 2007 |
Last Updated: | February 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00459680 |
Health Authority: | United States: Food and Drug Administration |
|
|
|